androgenic alopecia
Conditions
Interventions
2% Minoxidil topical solution group:None.
5% Minoxidil topical solution group:None.
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: a. The clinical diagnosis is androgenetic alopecia (AGA). b. The doctor's prescription includes minoxidil solution. c. Capable of completing research-related assessments and recordings. d. Willing to participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: a. Patients with serious mental health problems. b. Patients who have previously used minoxidil lotion under the guidance of a physician and it was ineffective. c. Other circumstances judged by the researchers as unsuitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Terminal hairs in the target area in the frontal and vertex regions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hair diameter variability;Hair follicle units with single hairs;Ratio of primary to secondary hairs in fixed field of view;7-point comparison scale (Global Aesthetic Improvement Scale);Scalp inflammation changes.; | — |
Countries
China
Contacts
Public ContactDingquan Yang
China-Japan Friendship Hospital
Outcome results
None listed